Approvals/NMPA/Recombinant Human Papillomavirus Bivalent (Types 16,18) Vaccine(Escherichia coli)

Approved

生物制品

Recombinant Human Papillomavirus Bivalent (Types 16,18) Vaccine(Escherichia coli)

厦门万泰沧海生物技术有限公司🇨🇳 National Medical Products Administration

Approval Id: 7ucugSCynfz
Approval Number: 国药准字S20190047
Generic Name: 双价人乳头瘤病毒疫苗(大肠杆菌)
Generic Name En: Recombinant Human Papillomavirus Bivalent (Types 16,18) Vaccine(Escherichia coli)
Trade Name: 馨可宁(Cecolin)
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 每瓶/支0.5ml，含重组人乳头瘤病毒16型L1蛋白40μg，重组人乳头瘤病毒18型L1蛋白20μg。
Reg Date: 2024-09-06
Company Name: 厦门万泰沧海生物技术有限公司
Company Address: 厦门市海沧区山边洪东路50号一层
Production Company Name: 厦门万泰沧海生物技术有限公司
Production Company Address: 福建省厦门市海沧区山边洪东路52号
Company Detail Path: /organization/sha-men-mo-tai-cang-hai-sheng-wu-ji-zhu-you-xian-gong-si
Production Company Detail Path: /organization/sha-men-mo-tai-cang-hai-sheng-wu-ji-zhu-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 6, 2024

Approval ID

7ucugSCynfz

Type

生物制品